Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Obesity (Silver Spring). 2022 May;30(5):1079-1090. doi: 10.1002/oby.23413. Epub 2022 Mar 31.
This study sought to assess whether diabetes affects coronary microvascular function in individuals with normal body weight.
Seventy-five participants (30 patients with type 2 diabetes [T2D] who were overweight [O-T2D], 15 patients with T2D who were lean [LnT2D], 15 healthy volunteers who were lean [LnHV], and 15 healthy volunteers who were overweight [O-HV]) without established cardiovascular disease were recruited. Participants underwent magnetic resonance imaging for assessment of subcutaneous, epicardial, and visceral adipose tissue areas, adenosine stress myocardial blood flow (MBF), and cardiac structure and function.
Stress MBF was reduced only in the O-T2D group (mean [SD], LnHV = 2.07 [0.47] mL/g/min, O-HV = 2.08 [0.42] mL/g/min, LnT2D = 2.16 [0.36] mL/g/min, O-T2D = 1.60 [0.28] mL/g/min; p ≤ 0.0001). Accumulation of visceral fat was evident in the LnT2D group at similar levels to the O-HV group (LnHV = 127 [53] cm , O-HV = 181 [60] cm , LnT2D = 182 [99] cm , O-T2D = 288 [72] cm ; p < 0.0001). Only the O-T2D group showed reductions in left ventricular ejection fraction (LnHV = 63% [4%], O-HV = 63% [4%], LnT2D = 60% [5%], O-T2D = 58% [6%]; p = 0.0008) and global longitudinal strain (LnHV = -15.1% [3.1%], O-HV= -15.2% [3.7%], LnT2D = -13.4% [2.7%], O-T2D = -11.1% [2.8%]; p = 0.002) compared with both control groups.
Patients with T2D and normal body weight do not show alterations in global stress MBF, but they do show significant increases in visceral adiposity. Patients with T2D who were overweight and had no prior cardiovascular disease showed an increase in visceral adiposity and significant reductions in stress MBF.
本研究旨在评估体重正常的 2 型糖尿病(T2D)患者的糖尿病是否会影响其冠状动脉微血管功能。
本研究共纳入了 75 名参与者(30 名超重的 2 型糖尿病患者[T2D] [O-T2D]、15 名非肥胖的 2 型糖尿病患者[T2D] [LnT2D]、15 名非肥胖的健康志愿者[LnHV]和 15 名超重的健康志愿者[O-HV]),他们均无已确诊的心血管疾病。所有参与者均接受磁共振成像检查,以评估皮下、心外膜和内脏脂肪组织面积、腺苷应激性心肌血流(MBF)以及心脏结构和功能。
仅在 O-T2D 组中观察到应激性 MBF 降低(平均[标准差],LnHV=2.07[0.47]mL/g/min,O-HV=2.08[0.42]mL/g/min,LnT2D=2.16[0.36]mL/g/min,O-T2D=1.60[0.28]mL/g/min;p≤0.0001)。LnT2D 组的内脏脂肪堆积与 O-HV 组相似(LnHV=127[53]cm,O-HV=181[60]cm,LnT2D=182[99]cm,O-T2D=288[72]cm;p<0.0001)。仅 O-T2D 组的左心室射血分数(LnHV=63%[4%],O-HV=63%[4%],LnT2D=60%[5%],O-T2D=58%[6%];p=0.0008)和整体纵向应变(LnHV=-15.1%[3.1%],O-HV=-15.2%[3.7%],LnT2D=-13.4%[2.7%],O-T2D=-11.1%[2.8%];p=0.002)与两个对照组相比均显著降低。
体重正常的 T2D 患者的整体应激性 MBF 没有改变,但内脏脂肪量显著增加。无既往心血管疾病的超重 T2D 患者的内脏脂肪量增加,且应激性 MBF 显著降低。